help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on September 7, 2006, doi:10.1164/rccm.200603-423OC

Am. J. Respir. Crit. Care Med., Volume 174, Number 11, December 2006, 1211-1220

A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200603-423OCv1
174/11/1211    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kraemer, R.
Right arrow Articles by Crameri, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kraemer, R.
Right arrow Articles by Crameri, R.

Submitted on March 24, 2006
Accepted on September 6, 2006

Effect of Allergic Broncho-pulmonary Aspergillosis on Lung Function in Children with Cystic Fibrosis

Richard Kraemer1*, Natascha Delosea1, Pietro Ballinari2, Sabina Gallati3, and Reto Crameri4

1 Department of Paediatrics, University of Berne, Berne, BE, Switzerland, 2 Department of Psychiatry, University of Berne, Berne, BE, Switzerland, 3 Division of Human Genetics, University of Berne, Berne, BE, Switzerland, 4 Swiss Institute of Allergy and Asthma Research, Davos, GR, Switzerland

* To whom correspondence should be addressed. E-mail: richard.kraemer{at}insel.ch.

Rationale. The relationship between sensitization to A. fumigatus (Af) and progression of pulmonary function is not yet established in cystic fibrosis (CF). Objectives. We aimed to evaluate onset of Af-sensitization and development of allergic broncho-pulmonary aspergillosis (ABPA), as well as to determine the physiological factors of lung function influencing these mechanisms in CF. Methods. Serial annual lung function tests performed in 122 CF-children (62 males; 60 females; age: 6-18 y), provided data pertaining to functional residual capacity (FRCpleth), lung clearance index (LCI), volume of trapped gas (VTG), effective specific airway resistance (sReff), and forced expiratory indices (FEV1, FEF50). Specific IgE to recombinant Af allergens rAspf1 and rAspf3, served as marker for sensitization, and to rAspf4 and rAspf6 as indication for a serological ABPA, clinically diagnosed (Nelson criteria). By linear mixed-effect model analysis 5 patient groups, (i) not sensitized and free from P. aeruginosa (PA), (ii) intermittently PA-colonized, (iii) chronically PA-infected, (iv) sensitized, and (v) ABPA, were retrospectively evaluated. Measurements and Main Results. Af sensitization was best reflected by increased rAspf1+3-specific IgE levels, whereas in most patients sensitization was preceded by PA infection. ABPA patients demonstrated the most severe progression in all lung function parameters, and FEF50, VTG and sReff were the best predictor (p<0.0001). However, regarding distinction between sensitization to Af and development of ABPA in the course of CF, chronic PA infection has to be taken into account. Conclusions. Airway narrowing, gas trapping and small airway disease are the major targets for functional derangement in ABPA.


Key words: Cystic fibrosis, A. fumigatus sensitization, allergic broncho-pulmonary aspergillosis, lung function, P. aeruginosa infection




This article has been cited by other articles:


Home page
ChestHome page
R. Agarwal
Allergic Bronchopulmonary Aspergillosis
Chest, March 1, 2009; 135(3): 805 - 826.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. J. Kozlowska, A. Bush, A. Wade, P. Aurora, S. B. Carr, R. A. Castle, A.-F. Hoo, S. Lum, J. Price, S. Ranganathan, et al.
Lung Function from Infancy to the Preschool Years after Clinical Diagnosis of Cystic Fibrosis
Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 42 - 49.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Latzin, D. Hartl, N. Regamey, U. Frey, M. H. Schoeni, and C. Casaulta
Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis
Eur. Respir. J., January 1, 2008; 31(1): 36 - 42.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Giavina-Bianchi, E. Oliveira, and J. Kalil
Specific IgE against Recombinant Allergens in Allergic Bronchopulmonary Aspergillosis
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 967a - 967a.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Crameri and R. Kraemer
Specific IgE against Recombinant Allergens in Allergic Bronchopulmonary Aspergillosis
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 967b - 968.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. J. Accurso
Update in Cystic Fibrosis 2006
Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 754 - 757.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society
  Red In Translatin